CORCYM
Medical Equipment ManufacturingLondon, United Kingdom501-1000 Employees
We are committed to be a leading company dedicated to Heart Surgeons and their patients by providing the best solutions to fight structural heart disease.
Strategic Industry Focus CORCYM operates within the high-growth medical equipment sector, specializing in solutions for structural heart disease, indicating ongoing demand for innovation and supporting long-term sales prospects in this niche.
Recent Expansion The company's acquisition of key manufacturing facilities from LivaNova and partnership with RUA Life Sciences showcase aggressive growth strategies and potential needs for advanced manufacturing technologies, quality management systems, and supply chain solutions.
Technological Ecosystem CORCYM utilizes a robust tech stack including cloud computing, enterprise analytics, and security, signaling opportunities to provide integrated software solutions, system enhancements, or cybersecurity services tailored for the medical manufacturing sector.
Financial Potential With revenues estimated between 10 and 25 million dollars, CORCYM presents a promising mid-sized market opportunity for scalable medical device solutions, continuous process improvements, or capital equipment upgrades.
Market Position Collaborations and acquisition activities indicate CORCYM’s ambition to strengthen its position in the cardiovascular device market, making it a strategic target for suppliers of innovative medical components, supply chain optimization, or research & development support services.
CORCYM uses 8 technology products and services including IBM Cognos Analytics, PTC Creo, Amazon Web Services, and more. Explore CORCYM's tech stack below.
| CORCYM Email Formats | Percentage |
| First.Last@corcym.com | 49% |
| First.MiddleLast@corcym.com | 2% |
| First.Last@corcym.com | 49% |
Medical Equipment ManufacturingLondon, United Kingdom501-1000 Employees
We are committed to be a leading company dedicated to Heart Surgeons and their patients by providing the best solutions to fight structural heart disease.
CORCYM's revenue is estimated to be in the range of $10M$25M
CORCYM's revenue is estimated to be in the range of $10M$25M